Cargando…

N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain

Intraneuronal insoluble inclusions made of Tau protein are neuropathological hallmarks of Alzheimer Disease (AD). Cleavage of Tau by legumain (LGMN) has been proposed to be crucial for aggregation of Tau into fibrils. However, it remains unclear if LGMN-cleaved Tau fragments accumulate in AD Tau inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlegel, Kerstin, Awwad, Khader, Heym, Roland G., Holzinger, David, Doell, Annika, Barghorn, Stefan, Jahn, Thomas R., Klein, Corinna, Mordashova, Yulia, Schulz, Michael, Gasparini, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854719/
https://www.ncbi.nlm.nih.gov/pubmed/31722749
http://dx.doi.org/10.1186/s40478-019-0831-2
_version_ 1783470265158598656
author Schlegel, Kerstin
Awwad, Khader
Heym, Roland G.
Holzinger, David
Doell, Annika
Barghorn, Stefan
Jahn, Thomas R.
Klein, Corinna
Mordashova, Yulia
Schulz, Michael
Gasparini, Laura
author_facet Schlegel, Kerstin
Awwad, Khader
Heym, Roland G.
Holzinger, David
Doell, Annika
Barghorn, Stefan
Jahn, Thomas R.
Klein, Corinna
Mordashova, Yulia
Schulz, Michael
Gasparini, Laura
author_sort Schlegel, Kerstin
collection PubMed
description Intraneuronal insoluble inclusions made of Tau protein are neuropathological hallmarks of Alzheimer Disease (AD). Cleavage of Tau by legumain (LGMN) has been proposed to be crucial for aggregation of Tau into fibrils. However, it remains unclear if LGMN-cleaved Tau fragments accumulate in AD Tau inclusions. Using an in vitro enzymatic assay and non-targeted mass spectrometry, we identified four putative LGMN cleavage sites at Tau residues N167-, N255-, N296- and N368. Cleavage at N368 generates variously sized N368-Tau fragments that are aggregation prone in the Thioflavin T assay in vitro. N368-cleaved Tau is not detected in the brain of legumain knockout mice, indicating that LGMN is required for Tau cleavage in the mouse brain in vivo. Using a targeted mass spectrometry method in combination with tissue fractionation and biochemical analysis, we investigated whether N368-cleaved Tau is differentially produced and aggregated in brain of AD patients and control subjects. In brain soluble extracts, despite reduced uncleaved Tau in AD, levels of N368-cleaved Tau are comparable in AD and control hippocampus, suggesting that LGMN-mediated cleavage of Tau is not altered in AD. Consistently, levels of activated, cleaved LGMN are also similar in AD and control brain extracts. To assess the potential accumulation of N368-cleaved Tau in insoluble Tau aggregates, we analyzed sarkosyl-insoluble extracts from AD and control hippocampus. Both N368-cleaved Tau and uncleaved Tau were significantly increased in AD as a consequence of pathological Tau inclusions accumulation. However, the amount of N368-cleaved Tau represented only a very minor component (< 0.1%) of insoluble Tau. Our data indicate that LGMN physiologically cleaves Tau in the mouse and human brain generating N368-cleaved Tau fragments, which remain largely soluble and are present only in low proportion in Tau insoluble aggregates compared to uncleaved Tau. This suggests that LGMN-cleaved Tau has limited role in the progressive accumulation of Tau inclusions in AD.
format Online
Article
Text
id pubmed-6854719
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68547192019-11-21 N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain Schlegel, Kerstin Awwad, Khader Heym, Roland G. Holzinger, David Doell, Annika Barghorn, Stefan Jahn, Thomas R. Klein, Corinna Mordashova, Yulia Schulz, Michael Gasparini, Laura Acta Neuropathol Commun Research Intraneuronal insoluble inclusions made of Tau protein are neuropathological hallmarks of Alzheimer Disease (AD). Cleavage of Tau by legumain (LGMN) has been proposed to be crucial for aggregation of Tau into fibrils. However, it remains unclear if LGMN-cleaved Tau fragments accumulate in AD Tau inclusions. Using an in vitro enzymatic assay and non-targeted mass spectrometry, we identified four putative LGMN cleavage sites at Tau residues N167-, N255-, N296- and N368. Cleavage at N368 generates variously sized N368-Tau fragments that are aggregation prone in the Thioflavin T assay in vitro. N368-cleaved Tau is not detected in the brain of legumain knockout mice, indicating that LGMN is required for Tau cleavage in the mouse brain in vivo. Using a targeted mass spectrometry method in combination with tissue fractionation and biochemical analysis, we investigated whether N368-cleaved Tau is differentially produced and aggregated in brain of AD patients and control subjects. In brain soluble extracts, despite reduced uncleaved Tau in AD, levels of N368-cleaved Tau are comparable in AD and control hippocampus, suggesting that LGMN-mediated cleavage of Tau is not altered in AD. Consistently, levels of activated, cleaved LGMN are also similar in AD and control brain extracts. To assess the potential accumulation of N368-cleaved Tau in insoluble Tau aggregates, we analyzed sarkosyl-insoluble extracts from AD and control hippocampus. Both N368-cleaved Tau and uncleaved Tau were significantly increased in AD as a consequence of pathological Tau inclusions accumulation. However, the amount of N368-cleaved Tau represented only a very minor component (< 0.1%) of insoluble Tau. Our data indicate that LGMN physiologically cleaves Tau in the mouse and human brain generating N368-cleaved Tau fragments, which remain largely soluble and are present only in low proportion in Tau insoluble aggregates compared to uncleaved Tau. This suggests that LGMN-cleaved Tau has limited role in the progressive accumulation of Tau inclusions in AD. BioMed Central 2019-11-13 /pmc/articles/PMC6854719/ /pubmed/31722749 http://dx.doi.org/10.1186/s40478-019-0831-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Schlegel, Kerstin
Awwad, Khader
Heym, Roland G.
Holzinger, David
Doell, Annika
Barghorn, Stefan
Jahn, Thomas R.
Klein, Corinna
Mordashova, Yulia
Schulz, Michael
Gasparini, Laura
N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain
title N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain
title_full N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain
title_fullStr N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain
title_full_unstemmed N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain
title_short N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain
title_sort n368-tau fragments generated by legumain are detected only in trace amount in the insoluble tau aggregates isolated from ad brain
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854719/
https://www.ncbi.nlm.nih.gov/pubmed/31722749
http://dx.doi.org/10.1186/s40478-019-0831-2
work_keys_str_mv AT schlegelkerstin n368taufragmentsgeneratedbylegumainaredetectedonlyintraceamountintheinsolubletauaggregatesisolatedfromadbrain
AT awwadkhader n368taufragmentsgeneratedbylegumainaredetectedonlyintraceamountintheinsolubletauaggregatesisolatedfromadbrain
AT heymrolandg n368taufragmentsgeneratedbylegumainaredetectedonlyintraceamountintheinsolubletauaggregatesisolatedfromadbrain
AT holzingerdavid n368taufragmentsgeneratedbylegumainaredetectedonlyintraceamountintheinsolubletauaggregatesisolatedfromadbrain
AT doellannika n368taufragmentsgeneratedbylegumainaredetectedonlyintraceamountintheinsolubletauaggregatesisolatedfromadbrain
AT barghornstefan n368taufragmentsgeneratedbylegumainaredetectedonlyintraceamountintheinsolubletauaggregatesisolatedfromadbrain
AT jahnthomasr n368taufragmentsgeneratedbylegumainaredetectedonlyintraceamountintheinsolubletauaggregatesisolatedfromadbrain
AT kleincorinna n368taufragmentsgeneratedbylegumainaredetectedonlyintraceamountintheinsolubletauaggregatesisolatedfromadbrain
AT mordashovayulia n368taufragmentsgeneratedbylegumainaredetectedonlyintraceamountintheinsolubletauaggregatesisolatedfromadbrain
AT schulzmichael n368taufragmentsgeneratedbylegumainaredetectedonlyintraceamountintheinsolubletauaggregatesisolatedfromadbrain
AT gasparinilaura n368taufragmentsgeneratedbylegumainaredetectedonlyintraceamountintheinsolubletauaggregatesisolatedfromadbrain